Omeprazole (Ome), cisapride (Cis), and placebo for heartburn‡
| Outcomes | Ome | Cis | Placebo | RBI (95% CI) | NNT (CI) |
|---|---|---|---|---|---|
| ‡Abbreviations defined in glossary; RBI, NNT, and CI calculated from data in article. | |||||
| Adequate heartburn control at 4 wk | 71% | — | 18% | 288% (179 to 451) | 2 (2 to 3) |
| 71% | 22% | — | 221% (139 to 338) | 3 (2 to 3) | |
| — | 22% | 18% | 21% (–21 to 87) | Not significant | |
| Adequate heartburn control at 8 wk | 76% | — | 30% | 151% (97 to 226) | 3 (2 to 3) |
| 76% | 40% | — | 90% (55 to 136) | 3 (3 to 4) | |
| — | 40% | 30% | 32% (–2 to 79) | Not significant | |
